Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Pluripotent stem cells models for Huntington's disease: prospects and challenges.

Carter RL, Chan AW.

J Genet Genomics. 2012 Jun 20;39(6):253-9. doi: 10.1016/j.jgg.2012.04.006. Epub 2012 May 9. Review.

2.

How can human pluripotent stem cells help decipher and cure Huntington's disease?

Perrier A, Peschanski M.

Cell Stem Cell. 2012 Aug 3;11(2):153-61. doi: 10.1016/j.stem.2012.07.015.

3.

Induced Pluripotent Stem Cells in Huntington's Disease: Disease Modeling and the Potential for Cell-Based Therapy.

Liu L, Huang JS, Han C, Zhang GX, Xu XY, Shen Y, Li J, Jiang HY, Lin ZC, Xiong N, Wang T.

Mol Neurobiol. 2016 Dec;53(10):6698-6708. Epub 2015 Dec 10. Review.

4.

Therapeutic potential of human adipose-derived stem cells in neurological disorders.

Chang KA, Lee JH, Suh YH.

J Pharmacol Sci. 2014;126(4):293-301. doi: 10.1254/jphs.14R10CP. Epub 2014 Nov 18. Review.

5.

The potential of alternate sources of cells for neural grafting in Parkinson's and Huntington's disease.

Drouin-Ouellet J.

Neurodegener Dis Manag. 2014;4(4):297-307. doi: 10.2217/nmt.14.26. Review.

PMID:
25313986
6.

Regenerative medicine in Huntington's disease: current status on fetal grafts and prospects for the use of pluripotent stem cell.

Bachoud-Lévi AC, Perrier AL.

Rev Neurol (Paris). 2014 Dec;170(12):749-62. doi: 10.1016/j.neurol.2014.10.007. Epub 2014 Nov 4. Review.

PMID:
25459124
7.

Stem cell therapy and cellular engineering for treatment of neuronal dysfunction in Huntington's disease.

Choi KA, Hwang I, Park HS, Oh SI, Kang S, Hong S.

Biotechnol J. 2014 Jul;9(7):882-94. doi: 10.1002/biot.201300560. Epub 2014 May 15. Review.

PMID:
24827816
8.

Pluripotent stem cell-based disease modeling: current hurdles and future promise.

Zeltner N, Studer L.

Curr Opin Cell Biol. 2015 Dec;37:102-10. doi: 10.1016/j.ceb.2015.10.008. Epub 2015 Nov 27. Review.

PMID:
26629748
9.

Monkey hybrid stem cells develop cellular features of Huntington's disease.

Laowtammathron C, Cheng ECh, Cheng PH, Snyder BR, Yang SH, Johnson Z, Lorthongpanich C, Kuo HC, Parnpai R, Chan AW.

BMC Cell Biol. 2010 Feb 5;11:12. doi: 10.1186/1471-2121-11-12.

11.
12.

The use of stem cells in regenerative medicine for Parkinson's and Huntington's Diseases.

Lescaudron L, Naveilhan P, Neveu I.

Curr Med Chem. 2012;19(35):6018-35. Review.

PMID:
22963567
13.

Impacts of recent advances in cardiovascular regenerative medicine on clinical therapies and drug discovery.

Murata M, Tohyama S, Fukuda K.

Pharmacol Ther. 2010 May;126(2):109-18. doi: 10.1016/j.pharmthera.2010.01.010. Epub 2010 Feb 13. Review.

PMID:
20156482
14.

Pluripotent hybrid stem cells from transgenic Huntington's disease monkey.

Laowtammathron C, Chan AW.

Methods Mol Biol. 2013;1010:61-77. doi: 10.1007/978-1-62703-411-1_5.

PMID:
23754219
15.

Stem cells for cell replacement therapy: a therapeutic strategy for HD?

Rosser A, Svendsen CN.

Mov Disord. 2014 Sep 15;29(11):1446-54. doi: 10.1002/mds.26026. Review.

PMID:
25216372
16.

De novo generation of HSCs from somatic and pluripotent stem cell sources.

Vo LT, Daley GQ.

Blood. 2015 Apr 23;125(17):2641-8. doi: 10.1182/blood-2014-10-570234. Epub 2015 Mar 11. Review.

17.

Directed differentiation of pluripotent stem cells: from developmental biology to therapeutic applications.

Irion S, Nostro MC, Kattman SJ, Keller GM.

Cold Spring Harb Symp Quant Biol. 2008;73:101-10. doi: 10.1101/sqb.2008.73.065. Epub 2009 Mar 27. Review.

PMID:
19329573
18.

Present state and future perspectives of using pluripotent stem cells in toxicology research.

Wobus AM, Löser P.

Arch Toxicol. 2011 Feb;85(2):79-117. doi: 10.1007/s00204-010-0641-6. Epub 2011 Jan 12. Review.

19.

Efficient derivation of human neuronal progenitors and neurons from pluripotent human embryonic stem cells with small molecule induction.

Parsons XH, Teng YD, Parsons JF, Snyder EY, Smotrich DB, Moore DA.

J Vis Exp. 2011 Oct 28;(56):e3273. doi: 10.3791/3273.

20.

Differentiation and enrichment of cardiomyocytes from human pluripotent stem cells.

Xu C.

J Mol Cell Cardiol. 2012 Jun;52(6):1203-12. doi: 10.1016/j.yjmcc.2012.03.012. Epub 2012 Mar 30. Review.

PMID:
22484618

Supplemental Content

Support Center